Recent advances in peptide design have transformed the approach to modulating protein-protein interactions (PPIs), a field that underpins much of cellular signalling and disease pathology. By ...
A team from the Flatiron Institute is leveraging supercomputing resources from the Argonne Leadership Computing Facility to advance the design of peptides with the aim of speeding up the search for ...
Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between ...
Hokkaido University researchers have developed a novel method to design and develop peptide antibiotics in large numbers, which will prove critical to controlling antibiotic resistance. Applications ...
NEW YORK, NY, January 24, 2025 — A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly ...
TORONTO--(BUSINESS WIRE)--ProteinQure Inc., a biotechnology company pioneering computational peptide therapeutics, announced today the close of an $11 million Series A financing round. The proceeds ...
SCIENCE CHINA Life Sciences published a research article online by Professor Yanfeng Gao’s team from the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University. They designed and ...
Objective: The development of a generalizable, fast, effective, scalable, translatable and economic purification platform is critical for the technical and economic success of mRNA-based therapeutics.
Researchers from Canada and the United States have created an artificial intelligence (AI) tool called PepMLM to target “undruggable” disease proteins. This development could lead to new treatments ...
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTC PINK:BBCMF)(Frankfurt:N790, WKN:A41QA9) ("LIR" or the "Company) is pleased to announce that it has commenced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results